洁特生物
(688026)
| 流通市值：15.69亿 | | | 总市值：15.71亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 520,200,418.65 | 539,133,692.05 | 515,711,670.39 | 521,421,683.83 |
| 应收票据及应收账款 | 106,027,611.95 | 127,541,590.16 | 120,145,785.32 | 108,143,986.43 |
| 应收账款 | 106,027,611.95 | 127,541,590.16 | 120,145,785.32 | 108,143,986.43 |
| 预付款项 | 8,129,424.8 | 5,329,774.69 | 5,667,811.91 | 4,505,192.65 |
| 其他应收款合计 | 6,567,250.8 | 4,736,626.48 | 5,463,228.58 | 5,721,488.33 |
| 存货 | 91,961,758.8 | 84,481,357.87 | 87,366,694.28 | 107,403,202.54 |
| 其他流动资产 | 11,540,487.14 | 9,724,839.32 | 9,184,070.97 | 6,681,415.9 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 744,426,952.14 | 770,947,880.57 | 743,539,261.45 | 753,876,969.68 |
| 非流动资产: | | | | |
| 长期股权投资 | 32,969,369.02 | 33,267,970.98 | 33,778,204.13 | 33,411,210.76 |
| 其他权益工具投资 | 28,700,225.77 | 28,766,904.16 | 28,317,509.19 | 28,317,509.19 |
| 投资性房地产 | 181,834,888.44 | 183,359,308.78 | - | - |
| 固定资产 | 376,539,487.76 | 385,890,248.82 | 552,450,013.16 | 560,466,682.39 |
| 在建工程 | 145,689,350.65 | 117,842,247.56 | 125,753,861.59 | 88,029,266.29 |
| 使用权资产 | 1,154,137.18 | 2,245,358.26 | 3,583,964.02 | 5,055,367.81 |
| 无形资产 | 53,293,681.23 | 53,638,133.39 | 58,851,171.03 | 59,227,155.6 |
| 递延所得税资产 | 5,602,315.35 | 5,592,313.59 | 7,853,303.15 | 7,702,637.1 |
| 其他非流动资产 | 40,315,801.58 | 44,501,844.5 | 44,896,423.9 | 47,234,921.74 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 866,099,256.98 | 855,104,330.04 | 855,484,450.17 | 829,444,750.88 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,610,526,209.12 | 1,626,052,210.61 | 1,599,023,711.62 | 1,583,321,720.56 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 27,345,280.97 | 39,149,751.91 | 33,350,123.94 | 36,456,877.4 |
| 应付账款 | 27,345,280.97 | 39,149,751.91 | 33,350,123.94 | 36,456,877.4 |
| 预收款项 | 279,081.19 | 462,529.31 | - | - |
| 合同负债 | 33,622,671.06 | 32,329,934.88 | 26,544,366.19 | 27,093,564.9 |
| 应付职工薪酬 | 11,325,634.94 | 11,907,445.44 | 8,119,722.41 | 7,729,256.24 |
| 应交税费 | 4,145,474.15 | 4,967,800.65 | 5,786,162.64 | 3,949,987.56 |
| 其他应付款合计 | 14,351,354.61 | 10,685,743.45 | 14,990,037.78 | 13,522,771.44 |
| 一年内到期的非流动负债 | 2,851,010.72 | 2,847,230.22 | 3,344,860.05 | 4,546,136.6 |
| 其他流动负债 | 1,182,957.22 | 1,053,025.23 | 1,255,278.39 | 1,196,618.15 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 95,103,464.86 | 103,403,461.09 | 93,390,551.4 | 94,495,212.29 |
| 非流动负债: | | | | |
| 应付债券 | 342,526,632.62 | 336,845,885.1 | 331,097,346.71 | 325,348,808.38 |
| 租赁负债 | 459,634.14 | 506,647.33 | 839,506.17 | 885,801.34 |
| 预计负债 | 1,076,536.34 | 1,009,652.78 | - | - |
| 递延收益 | 25,647,750.2 | 26,663,715.74 | 27,679,681.28 | 27,675,646.82 |
| 递延所得税负债 | 35,283.19 | 35,283.19 | 1,739,516.93 | 1,739,516.93 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 369,745,836.49 | 365,061,184.14 | 361,356,051.09 | 355,649,773.47 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 464,849,301.35 | 468,464,645.23 | 454,746,602.49 | 450,144,985.76 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 140,363,220 | 140,363,220 | 140,363,220 | 140,363,220 |
| 其他权益工具 | 129,905,536.4 | 129,905,536.4 | 129,905,536.4 | 129,905,536.4 |
| 资本公积 | 413,562,031.59 | 413,562,031.59 | 421,160,941.92 | 421,160,899.68 |
| 减:库存股 | 20,067,845.19 | - | - | - |
| 其他综合收益 | 535,811.91 | 591,258.54 | 218,882.81 | 218,882.81 |
| 盈余公积 | 60,562,454.98 | 60,562,454.98 | 59,893,608.37 | 59,893,608.37 |
| 未分配利润 | 420,159,670.65 | 411,981,122.47 | 391,822,781.13 | 380,823,351.74 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,145,020,880.34 | 1,156,965,623.98 | 1,143,364,970.63 | 1,132,365,499 |
| 少数股东权益 | 656,027.43 | 621,941.4 | 912,138.5 | 811,235.8 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,145,676,907.77 | 1,157,587,565.38 | 1,144,277,109.13 | 1,133,176,734.8 |
| 负债和股东权益合计 | 1,610,526,209.12 | 1,626,052,210.61 | 1,599,023,711.62 | 1,583,321,720.56 |
| 公告日期 | 2024-04-27 | 2024-04-20 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |